| The pharmaceutical industry is "sunrise industry", its healthy development is relating to the people’s livelihood and national security. All countries in the world attach great importance to the development of their pharmaceutical industry. Since the reform and opening up, the rapid development of our economy has commanded the attention of the world, and the pharmaceutical industry also develops vigorously, showing a good momentum, together with more and more R&D activities. However, many problems and dilemma are exposed during the R&D of China’s medicine manufacturing enterprises during the rapid development:The status of market competition, changes in market demand for new products, the external financial environment, FDI, industrial agglomeration and so on, which all influence the R&D of our medicine manufacturing enterprises apparently.This article is on the basis of an in-depth know and study of important position and development status of the status of market competition (the medical manufacturing enterprises, pharmaceutical research), medical manufacture enterprises’ R&D strategy, studying the external environmental factors which influence our medical manufacturing enterprises research and development, including industrial competition, enterprise scale, new products’ market demand, enterprises’ external funds raising environment (mainly analyze the government funds and loans from financial institutions), clustering in the pharmaceutical manufacturing industry, as well as foreign direct investment. This study mainly uses the method of panel data model in econometrics, through four hypotheses constructing an function formula with ten empirical test, collecting, analyzing, and processing data via Eviews6.0, and finally drawing relevant conclusion:Industry competition have negative effects on medicine manufacture enterprise development; The scale of the enterprise promotes enterprise R&D; New products’ market demand has positive influence on R&D input; As an important part of the enterprise R&D funds raising, the effects of government funds and loans from financial institutions have not yet reached the ideal level, there is still lots of potential to develop; Industry funds generated by industrial agglomeration and external effects of R&D provide a favorable external environment, helping enterprises’ research and development; Foreign direct investment (FDI) influence the flow of R&D talents, and promote the enterprise to devote more R&D human resource, but did not show benefit on the enterprises development funds’ input and output. |